<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HD4C76274A308437A80DA99664F016253" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 5506 IH: Hospitals As Naloxone Distribution Sites Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-09-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5506</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230914">September 14, 2023</action-date><action-desc><sponsor name-id="P000620">Ms. Pettersen</sponsor> (for herself, <cosponsor name-id="S001216">Ms. Schrier</cosponsor>, and <cosponsor name-id="B001315">Ms. Budzinski</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committees on <committee-name committee-id="HWM00">Ways and Means</committee-name>, and <committee-name committee-id="HAS00">Armed Services</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend titles XVIII and XIX of the Social Security Act and title 10, United States Code, to provide no-cost coverage for the preventive distribution of opioid overdose reversal drugs.</official-title></form><legis-body id="H1960705033754383A0C228A6559018BC" style="OLC"><section id="H9B053524FE2248E2BE118149A29C3DBD" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Hospitals As Naloxone Distribution Sites Act</short-title></quote> or the <quote><short-title>HANDS Act</short-title></quote>.</text></section><section id="H54836B6703CD4B93A1ED6CA70990DBE2"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds the following:</text><paragraph id="HB7192EB26DEA468B97727FDF32CC6286"><enum>(1)</enum><text>Opioid use disorder is a treatable brain disease from which people can recover.</text></paragraph><paragraph id="H88306EEF7DA7455786055D8E3F5FC195"><enum>(2)</enum><text>Individuals living with opioid use disorder, those who use opioids for chronic pain, and those who use illicit substances that may be contaminated with fentanyl or other illicit additives are at high risk for fatal overdose.</text></paragraph><paragraph id="H9EB319B28834473EB22585700C09B784"><enum>(3)</enum><text>Individuals at-risk of overdose are frequently cared for in emergency departments and hospitals, making these locations ideal places to screen and intervene. In addition, medical providers have the knowledge and ability to provide medically accurate information, but also treat the disease of addiction once a person is ready for treatment.</text></paragraph><paragraph id="HF6B57AFF516740EE8BE638F476403A79"><enum>(4)</enum><text>Overdose deaths are preventable with lifesaving opioid overdose reversal medications like naloxone. Two-thirds of fatal overdoses have a witness, who can intervene and prevent overdose death if they have access to opioid antagonists.</text></paragraph><paragraph id="HEE60F5E326894C8C95F4DF25BDF0EA7A"><enum>(5)</enum><text>Just as individuals with life-threatening allergies should carry an EpiPen, individuals and close contacts of those with opioid use disorder should carry an opioid overdose reversal medication.</text></paragraph><paragraph id="H01826F5C809F4DC0AF83C9E59088D295"><enum>(6)</enum><text>While over the counter (OTC) access to reversal agents may increase their availability to certain populations, the hurdles to access these medications for many of the most at-risk patients will still remain. These hurdles include out of pocket costs, transportation or access to pharmacies or other areas carrying OTC naloxone, stigma by pharmacy staff, addiction-related compromised executive function, and more. Therefore, hospitals are uniquely positioned as a point of distribution to best serve those who would most benefit.</text></paragraph><paragraph id="HF3A00D8BC4984EC3A6F3523790E294A9"><enum>(7)</enum><text display-inline="yes-display-inline">It is the intent of Congress to increase access for all individuals with opioid use disorder, and other risk factors, to opioid overdose reversal medication so that if they experience an overdose, they will have a second chance. As long as there is breath, there is hope for recovery.</text></paragraph></section><section id="HAF6A23F240614B8C8F553E77641F1983"><enum>3.</enum><header>No-cost coverage of preventive opioid overdose reversal drugs</header><subsection id="H706E2599D41644F39979FBECC0FD8228"><enum>(a)</enum><header>Coverage under Medicare</header><paragraph id="HADC4280DBE6F49DC9044B811071C42C0"><enum>(1)</enum><header>Coverage</header><text display-inline="yes-display-inline">Section 1861(s)(2) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x(s)(2)</external-xref>) is amended—</text><subparagraph id="H8B7BC27DA6054588A9B3207312B58836"><enum>(A)</enum><text>in subparagraph (JJ), by adding “and” after the semicolon at the end; and </text></subparagraph><subparagraph id="H686AC1EBA83A4CA69C3B0AA53E3D7C76"><enum>(B)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="HB49FA71A0746444FB7795095A04A0BA9" display-inline="no-display-inline"><subparagraph id="H16E830DF7747465EA007B511EB8D6ADE"><enum>(KK)</enum><text display-inline="yes-display-inline">a preventive opioid overdose reversal drug (as defined in subsection (nnn)) furnished on or after January 1, 2024;</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="HBEB4CE44EEE541D7A3D468011AE5717C"><enum>(2)</enum><header>Preventive opioid overdose reversal drug defined</header><text>Section 1861 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x</external-xref>) is amended by adding at the end the following new subsection:</text><quoted-block style="OLC" id="HA1CFDD8E9DF449C1951B6C4DCCFA06B4" display-inline="no-display-inline"><subsection id="HA5EC4B1C38B84D59AD290AFD490407BC"><enum>(nnn)</enum><header>Preventive opioid overdose reversal drug</header><text display-inline="yes-display-inline">The term <term>preventive opioid overdose reversal drug</term> means an opioid overdose reversal drug that is furnished by a physician, nurse practitioner, physician assistant, or other attending clinical personnel (as determined by the Secretary by regulation) to an individual who is an inpatient of a hospital, critical access hospital, or rural emergency hospital, or is a patient of the emergency department of such a hospital or an ambulatory surgical center, but only if—</text><paragraph id="HAB0B00579B3E4671813DC37C26E6686D"><enum>(1)</enum><text>such physician, nurse practitioner, physician assistant, or attending clinical professional determines that such individual is at risk for an opioid overdose; and</text></paragraph><paragraph id="HBDD46CFF8A224402A09E3270DA2D9BB8"><enum>(2)</enum><text>such drug is furnished at the time such individual is discharged from the hospital or leaves the emergency department or ambulatory surgical center, as the case may be, together with instructions for the administration of such drug.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph><paragraph id="HFEB7E46CB34646B5AEBBDC6FFCA23082" commented="no"><enum>(3)</enum><header>Prohibition of cost sharing</header><text>Section 1833 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395l">42 U.S.C. 1395l</external-xref>) is amended—</text><subparagraph id="H6DC17389A4424C8B9A8FB777C5C7638C" commented="no"><enum>(A)</enum><text>in subsection (a)(1)—</text><clause id="HE9C43C6B48A14DD6965BD33E659261A0"><enum>(i)</enum><text>in subparagraph (S)(i), by striking <quote>subparagraph (EE),</quote> and inserting <quote>subparagraphs (EE) and (II),</quote>; </text></clause><clause id="H71F60E9CE3BC487B96BF02F582F4B1BF" display-inline="no-display-inline" commented="no"><enum>(ii)</enum><text>in subparagraph (GG), by striking <quote>and</quote> at the end; and</text></clause><clause id="H0A585978107C4B079945B8A920387997" commented="no"><enum>(iii)</enum><text>by inserting <quote>, and (II) with respect to a preventive opioid overdose reversal drug (as defined in section 1861(nnn)) furnished on or after January 1, 2024, the amounts paid shall be 100 percent of the lesser of the actual charges for such drug or the amount determined under section 1842(o)</quote> before the semicolon at the end; and</text></clause></subparagraph><subparagraph id="H311C170821BC4C218057B78E85E2303D" commented="no"><enum>(B)</enum><text>in subsection (b)—</text><clause id="H67A75C13C4824FAE989652745AE02A04" commented="no"><enum>(i)</enum><text>by striking <quote>, and (13)</quote> and inserting <quote>(13)</quote>; and</text></clause><clause id="H1C37FDA062AB42A2AF7CA166C7A7CBA9" commented="no"><enum>(ii)</enum><text>by striking <quote>section 1861(n)..</quote> and inserting <quote>section 1861(n), and (14) such deductible shall not apply with respect to a preventive opioid reversal drug (as defined in section 1861(nnn)) furnished on or after January 1, 2024.</quote>.</text></clause></subparagraph></paragraph><paragraph id="H5777B09238A448CDB458F98FEA993B8E"><enum>(4)</enum><header>Prohibition of cost sharing for Medicare Advantage plans</header><text>Section 1852(a)(1)(B) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-22">42 U.S.C. 1395w–22(a)(1)(B)</external-xref>) is amended—</text><subparagraph id="H8E5C8A6F2DF746BF8B3B36D135B87A8F"><enum>(A)</enum><text>in clause (iv)—</text><clause id="H86DE300A8CC64000983D7462C2147F28"><enum>(i)</enum><text>by redesignating subclause (VIII) as subclause (IX); and</text></clause><clause id="H50B400461DF14E2CB8CE6F23987F76D8"><enum>(ii)</enum><text>by inserting after subclause (VII) the following new subclause:</text><quoted-block style="OLC" id="H5EF9B2273A174B09949B49EF9C3757C9" display-inline="no-display-inline"><subclause id="H6AD21533A903405FB6AECC91F8DDA77C"><enum>(VIII)</enum><text display-inline="yes-display-inline">A preventive opioid reversal drug (as defined in section 1861(nnn)).</text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></clause></subparagraph><subparagraph id="HF26B338EE5724706A57C13827F09C301"><enum>(B)</enum><text>in clause (v), by striking <quote>and (VI)</quote> and inserting <quote>(VI), and (VIII)</quote>. </text></subparagraph></paragraph></subsection><subsection id="H451ED1B2C2DD443BBD5FB4C64BD30E1D"><enum>(b)</enum><header>Coverage under Medicaid</header><paragraph id="HDC895846B54E478F802AAAEA15440CB8"><enum>(1)</enum><header>Mandatory coverage</header><subparagraph id="H2816164EAE3144B9846475724BC35660"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1902(a)(10)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396a">42 U.S.C. 1396a(a)(10)(A)</external-xref>) is amended by striking <quote>and (30)</quote> and inserting <quote>(30), and (31)</quote>.</text></subparagraph><subparagraph id="H8DEACA8F30074F6A95514308936A2AAD"><enum>(B)</enum><header>Alternative benefit plans</header><text display-inline="yes-display-inline">Section 1937(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396u-7">42 U.S.C. 1396u–7(b)</external-xref>) is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H44D5CA2EFC7B4F6EB3275AEBD81AFF95" display-inline="no-display-inline"><paragraph id="H9F21382ACCDB43B5BCA5934CED1E400F"><enum>(9)</enum><header>Preventive opioid overdose reversal drugs</header><text display-inline="yes-display-inline">Notwithstanding the previous provisions of this section, a State may not provide for medical assistance through enrollment of an individual with benchmark coverage or benchmark-equivalent coverage under this section unless, beginning on January 1, 2024, such coverage includes (and does not impose any deduction, cost sharing, or similar charge for) preventive opioid overdose reversal drugs described in section 1861(nnn)).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H20E1A5C927B449A2AF6582F877EB19E0"><enum>(2)</enum><header>Inclusion in medical assistance</header><subparagraph id="H7DA958D45E8C4C139507BC675E67B9F2"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1905(a) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396d">42 U.S.C. 1396d(a)</external-xref>) is amended—</text><clause id="H5E55E5BE17704E14ACD698EA776FEB88" display-inline="no-display-inline"><enum>(i)</enum><text>in paragraph (30), by striking <quote>and</quote> at the end;</text></clause><clause id="HE1E9FCAF27CA45E6B644CE555A7737C2"><enum>(ii)</enum><text>by redesignating paragraph (31) as paragraph (32); and</text></clause><clause id="HB711348AA1E54878BFBF2BEEF01F7BF3"><enum>(iii)</enum><text>by inserting after paragraph (30) the following new paragraph:</text><quoted-block style="OLC" id="HCC7AF1A1557F48E4AA988FE19AD931A8" display-inline="no-display-inline"><paragraph id="H92D5EF6118F94498A424F3AA672C2D21"><enum>(31)</enum><text display-inline="yes-display-inline">beginning January 1, 2024, preventive opioid overdose reversal drugs described in section 1861(nnn); and</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></clause></subparagraph></paragraph><paragraph id="H7880CC6A867843828C7F50B694E8961B" commented="no"><enum>(3)</enum><header>Application of rebate requirements</header><text>Section 1927 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396r-8">42 U.S.C. 1396r–8</external-xref>) is amended—</text><subparagraph id="H496DC36BCFDE4E64A62C2ED3435CB2A1" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">in subsection (d)(7), by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="H15155D529BB54E21AFD8644639FC769A" display-inline="no-display-inline"><subparagraph id="H56EAEBA6031E4D45AA96F44E9AE44400" commented="no"><enum>(F)</enum><text display-inline="yes-display-inline">Preventive opioid overdose reversal drugs described in section 1861(nnn) that are furnished as medical assistance in accordance with section 1905(a)(31) and section 1902(a)(10)(A).</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph id="H747494442D134ECC971F4BF6E5C10EDB" commented="no" display-inline="no-display-inline"><enum>(B)</enum><text>in subsection (k)(4)—</text><clause id="HCB291F4F8C534E3196F8503A7BECD027" commented="no"><enum>(i)</enum><text>by striking <quote>If a State plan</quote> and inserting: </text><quoted-block style="OLC" id="HB59F481097484EB8B1DC1FF5D0C2FD6C" display-inline="no-display-inline"><subparagraph id="H39ACF87CB9E84B83BE59CB7B0E259AC7" commented="no"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">If a State plan</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></clause><clause id="H578E2D9F1952465A9F0674BF1D814816" commented="no"><enum>(ii)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="HBD3C7E3B515643938D2563D44045672B" display-inline="no-display-inline"><subparagraph id="HCC5109328B0C483FAE8138FBDFF8E29A" commented="no"><enum>(B)</enum><header>Preventive opioid overdose reversal drugs</header><text display-inline="yes-display-inline">Beginning January 1, 2024, in applying paragraph (2)(A) to a preventive opioid overdose reversal drug described in section 1861(nnn), such drug shall be deemed a prescribed drug for purposes of section 1905(a)(12).</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></clause></subparagraph></paragraph><paragraph id="H3C6CAA8659D049BF99691BE54C550DFC" commented="no"><enum>(4)</enum><header>Prohibition of cost sharing</header><subparagraph id="H0EC6DAE7141E4955B5CBF20ADBC83E71" commented="no"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1916 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396o">42 U.S.C. 1396o</external-xref>) is amended—</text><clause id="H5F9B2AA5C0FE47DC8BAFFC54EEB0B05C"><enum>(i)</enum><text>in subsection (a)(2)—</text><subclause id="H105994628CA54189B05BB7F49D497E75" commented="no" display-inline="no-display-inline"><enum>(I)</enum><text>in subparagraph (I), by striking <quote>or</quote> at the end;</text></subclause><subclause id="HB5A21CCA855642048D90CE4FC0C679FA" commented="no"><enum>(II)</enum><text>in subparagraph (J), by striking <quote>; and</quote> at the end and inserting <quote>, or</quote>; and</text></subclause><subclause id="H80EC4AC41836460381088F318FA255A0" commented="no"><enum>(III)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HFEC090A072EB4893B9EC2845D5BB204D"><subparagraph id="H595F2534A24540E2BAA4D0FAC7E0E9FD" commented="no"><enum>(K)</enum><text display-inline="yes-display-inline">beginning January 1, 2024, preventive opioid overdose reversal drugs described in section 1861(nnn); and</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></subclause></clause><clause id="H438D1CF1562A4C3397F1FC05FD552E2E"><enum>(ii)</enum><text>in subsection (b)(2)—</text><subclause id="HF183DBA8DADF413C8A3534FFF0C587B9" commented="no" display-inline="no-display-inline"><enum>(I)</enum><text>in subparagraph (I), by striking <quote>or</quote> at the end;</text></subclause><subclause id="H5678660782324BF283A69AE9CBE73D93" commented="no"><enum>(II)</enum><text>in subparagraph (J), by striking <quote>; and</quote> at the end and inserting <quote>, or</quote>; and</text></subclause><subclause id="HF4B7B6B3C53143C6BAFC436741EC5808" commented="no"><enum>(III)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H66BD0B53226E46B2B89265C61252F3CA"><subparagraph id="HB81169F1785A4F0291B16874262741C9" commented="no"><enum>(K)</enum><text display-inline="yes-display-inline">beginning January 1, 2024, preventive opioid overdose reversal drugs described in section 1861(nnn); and</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subclause></clause></subparagraph><subparagraph id="HE5BA7845013642CE82E62F8FA910BF93" commented="no"><enum>(B)</enum><header>Application to alternative cost sharing</header><text display-inline="yes-display-inline">Section 1916A(b)(3)(B) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396o-1">42 U.S.C. 1396o–1(b)(3)(B)</external-xref>) is amended by adding at the end the following new clause:</text><quoted-block style="OLC" id="HEF93E5A6E4B540AB81F22EDA1DE8750E" display-inline="no-display-inline"><clause id="H1782F90E0294464398CAE09A3BBA0E86" commented="no"><enum>(xv)</enum><text display-inline="yes-display-inline">Beginning January 1, 2024, preventive opioid overdose reversal drugs described in section 1861(nnn).</text></clause><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></subsection><subsection id="H39B447F7F17B484E98729A575C16780F" commented="no"><enum>(c)</enum><header>Coverage under TRICARE</header><text>Section 1074g of title 10, United States Code, is amended as follows:</text><paragraph id="H399C9E0E1BA54114BAB268D80A6530CB"><enum>(1)</enum><text>In subsection (a)(6), by adding at the end the following new subparagraph:</text><quoted-block style="USC" id="HA5CEFBEB9B5E426599308811C9BCD0D9" display-inline="no-display-inline"><subparagraph id="H7C7C13BD450F435082543FE74870339C" indent="up2" commented="no"><enum>(D)</enum><text display-inline="yes-display-inline">Notwithstanding subparagraphs (A) through (C), beginning on January 1, 2024, an eligible covered beneficiary shall not be required to pay a cost-sharing amount for a preventive opioid overdose reversal drug.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph><paragraph id="H3C4F5A8143274B82B75E75ABF5BCC38D"><enum>(2)</enum><text>In subsection (i), by adding at the end the following new paragraph:</text><quoted-block style="USC" id="H57CFB70564974B2FA7CCE2E6E641EF10" display-inline="no-display-inline"><paragraph id="H5A8A1624EA594E20AF91DEC3428CB0AE"><enum>(5)</enum><text display-inline="yes-display-inline">The term <term>preventive opioid overdose reversal drug</term> has the meaning given such term in section 1861 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x</external-xref>).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection></section><section id="H1DC68F9BC7EB4803BD04258B476DBBD4"><enum>4.</enum><header>Regulatory guidance</header><text display-inline="no-display-inline">Not later than 1 year after the date of the enactment of this Act, the Commissioner of Food and Drugs shall issue guidance for State boards of pharmacy, nursing, and medicine with respect to—</text><paragraph id="H8CE0342467D64EE5A17F9E9B769A6ED7"><enum>(1)</enum><text>enhancing safe and effective hospital-based dispensing and distribution of opioid overdose reversal drugs; and</text></paragraph><paragraph id="H0F93353C265C4E408C53073E7509CA45"><enum>(2)</enum><text display-inline="yes-display-inline">eliminating barriers to such dispensing and distribution.</text></paragraph></section></legis-body></bill> 

